Table 1 Patient characteristics
Population (N = 54) | ||
|---|---|---|
Median | [range] | |
Age | 65 | [41–87] |
N | % | |
Sex | ||
Men | 42 | 77.8 |
Women | 12 | 22.2 |
ECOG | ||
0 | 20 | 37.0 |
1 | 25 | 46.3 |
2 | 8 | 14.8 |
3 | 1 | 1.9 |
Stage of the tumor at diagnosis | ||
0 | 3 | 5.6 |
1 | 15 | 27.7 |
2 | 13 | 24.1 |
3 | 7 | 13.0 |
4 | 16 | 29.6 |
Primary Location | ||
Upper Urinary Tract | 3 | 5.6 |
Bladder | 51 | 94.4 |
Type of predominant cells | ||
transitional cell carcinoma | 31 | 57.4 |
Other | 14 | 25.9 |
Not available | 9 | 16.7 |
Type of cancer at time of enrollment | ||
Metastatic | 44 | 81.5 |
Locally advanced | 10 | 18.5 |
Sites of metastasis (could be more than one) | ||
Lung | 20 | 37.0 |
Pleura | 1 | 1.9 |
Liver | 21 | 38.9 |
Bones | 22 | 40.7 |
Brain | 2 | 3.7 |
Nodes | 27 | 50 |
Other | 11 | 20.4 |
Neoadjuvant Chemotherapy | ||
Yes | 6 | 11.1 |
No | 48 | 88.9 |
Adjuvant Chemotherapy | ||
Yes | 13 | 24.1 |
No | 41 | 75.9 |